|
|
Post by lojothehus on Jan 25, 2017 11:37:32 GMT -5
I hate to beat this drum to death and maybe I am speaking mainly through frustration on my part as opposed to analytically thinking before I speak? However, the job of a good hype man, such as Flava Flav of Public Enemy, is to get the crowd energized....get them interested in the music.....ultimately selling the brand, making people feel good about the group.
MNKD needs someone like a Flava Flav! Matt and Mike, you guys need to get someone to post, to talk, to inform, to brag, to sale the product. Come on, normal A1C's; no needles; create a great depiction of that, put it on your web page. Brag about it, brag about throwing the needles away and trust me it will catch on. Brag about the sales the reps, brag about he pending deals, label changes, etc. Do not be scared about it falling through because trust me....we are getting tired of the future promises anyway. One more thing, say something on the website and stop waiting for conferences. Let us follow the direction of the company....please. |
|
|
|
Post by agedhippie on Jan 25, 2017 11:55:52 GMT -5
I hate to beat this drum to death and maybe I am speaking mainly through frustration on my part as opposed to analytically thinking before I speak? However, the job of a good hype man, such as Flava Flav of Public Enemy, is to get the crowd energized....get them interested in the music.....ultimately selling the brand, making people feel good about the group.
MNKD needs someone like a Flava Flav! Matt and Mike, you guys need to get someone to post, to talk, to inform, to brag, to sale the product. Come on, normal A1C's; no needles; create a great depiction of that, put it on your web page. Brag about it, brag about throwing the needles away and trust me it will catch on. Brag about the sales the reps, brag about he pending deals, label changes, etc. Do not be scared about it falling through because trust me....we are getting tired of the future promises anyway. One more thing, say something on the website and stop waiting for conferences. Let us follow the direction of the company....please. You realize what you are suggesting is illegal and will have both the FDA and the SEC after Mannkind? The FDA will not allow a company to promote benefits that are not supported by trial data, and the SEC limit what you can say about the company. Although shareholder suits are probably a bigger risk if you go down this route - especially if the insurer can prove negligence and pass the cost back to Mannkind. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 25, 2017 12:00:54 GMT -5
MNKD needs someone like a Flava Flav! Matt and Mike, you guys need to get someone to post, to talk, to inform, to brag, to sale the product. Come on, normal A1C's; no needles; create a great depiction of that, put it on your web page. Brag about it, brag about throwing the needles away and trust me it will catch on. Brag about the sales the reps, brag about he pending deals, label changes, etc. Do not be scared about it falling through because trust me....we are getting tired of the future promises anyway. One more thing, say something on the website and stop waiting for conferences. Let us follow the direction of the company....please. Right now they are busy training the reps. Some of the folks here know when the training will be done and then may be they will start on your recommendations. |
|
|
|
Post by careful2invest on Jan 25, 2017 12:08:38 GMT -5
I hate to beat this drum to death and maybe I am speaking mainly through frustration on my part as opposed to analytically thinking before I speak? However, the job of a good hype man, such as Flava Flav of Public Enemy, is to get the crowd energized....get them interested in the music.....ultimately selling the brand, making people feel good about the group.
MNKD needs someone like a Flava Flav! Matt and Mike, you guys need to get someone to post, to talk, to inform, to brag, to sale the product. Come on, normal A1C's; no needles; create a great depiction of that, put it on your web page. Brag about it, brag about throwing the needles away and trust me it will catch on. Brag about the sales the reps, brag about he pending deals, label changes, etc. Do not be scared about it falling through because trust me....we are getting tired of the future promises anyway. One more thing, say something on the website and stop waiting for conferences. Let us follow the direction of the company....please. I agree that there needs to be more of a prominent public voice promoting MNKD. BUT Flavor flav?? His ship has sailed. We can certainly up the ante from him! I dont think that Damon Dash is the best face for AFREZZA either, but Flavor flav definitely is going the wrong direction. There are many famous people with Diabetes from which to choose. Having more than a few on board would start the wave. One thing I know for certain is that MNKD needs to hire a professional advertising promoter to effectively lay out the launch strategy of AFREZZA and TECHNOSPHERE, if they have not already. While all of our ideas make for good conversation, unless you are in the advertising industry, we should leave it to the pros. Hiring the right (competent) people to effectively lay out an advertising plan makes the most sense to me. Hire the correct tradesman for the trade. Simple as that. It needs to be cutting edge and on point! Nothing less than perfection. After billions of dollars have already been spent to get us this far, MNKD cannot afford to lose the war! We'll see what MNKD comes up with. I have not understood why after two plus years after FDA approval, many Endo's and GP's still have never heard of AFREZZA or TECHNOSPHERE! It just does not make sense! GLTA TRUE LONGS! |
|
|
|
Post by madog365 on Jan 25, 2017 12:20:40 GMT -5
I have been a vocal supporter for hiring a public relations person for MNKD, or at the very least contracting out to a PR agency. I've emailed IR about this as well, it's a huge deficiency for the company and frankly i'm shocked they haven't solved this already. You can have the best product in the world, but if no one knows about you will still fail at business. PR professionals are not expensive hires and can make all the difference when it comes to getting media exposure.
Matt said Mannkind 2.0 would be a company built on transparency and communication. So far they have not lived up to that promise.
|
|
|
|
Post by lojothehus on Jan 25, 2017 12:38:31 GMT -5
You realize what you are suggesting is illegal and will have both the FDA and the SEC after Mannkind? The FDA will not allow a company to promote benefits that are not supported by trial data, and the SEC limit what you can say about the company. Although shareholder suits are probably a bigger risk if you go down this route - especially if the insurer can prove negligence and pass the cost back to Mannkind. Read more: mnkd.proboards.com/thread/7090/bring-noise#ixzz4WnPKleST
What is illegal about saying "no needles?" What is illegal about saying that Afrezza lowers A1C's? Why would shareholders file a lawsuit over transparency? |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 25, 2017 12:56:13 GMT -5
You realize what you are suggesting is illegal and will have both the FDA and the SEC after Mannkind? The FDA will not allow a company to promote benefits that are not supported by trial data, and the SEC limit what you can say about the company. Although shareholder suits are probably a bigger risk if you go down this route - especially if the insurer can prove negligence and pass the cost back to Mannkind. Read more: mnkd.proboards.com/thread/7090/bring-noise#ixzz4WnPKleST
What is illegal about saying "no needles?" What is illegal about saying that Afrezza lowers A1C's? Why would shareholders file a lawsuit over transparency? Drugs are regulated and you cannot claim Afrezza lowers A1c unless there is a clinical trial. lets end the discussion with that. Even some docs write off the twitter results as anecdotal and paid shills. |
|
|
|
Post by babaoriley on Jan 25, 2017 13:06:29 GMT -5
A Trump tweet saying how great Afrezza is would be helpful. Too bad someone close to him isn't on it and loving it.
Lojo, as iam2 says, the company is pretty well hamstrung relative to beating the drum as you suggest.
|
|
|
|
Post by fldave007 on Jan 25, 2017 13:07:18 GMT -5
You realize what you are suggesting is illegal and will have both the FDA and the SEC after Mannkind? The FDA will not allow a company to promote benefits that are not supported by trial data, and the SEC limit what you can say about the company. Although shareholder suits are probably a bigger risk if you go down this route - especially if the insurer can prove negligence and pass the cost back to Mannkind. Read more: mnkd.proboards.com/thread/7090/bring-noise#ixzz4WnPKleST
What is illegal about saying "no needles?" What is illegal about saying that Afrezza lowers A1C's? Why would shareholders file a lawsuit over transparency? Drugs are regulated and you cannot claim Afrezza lowers A1c unless there is a clinical trial. lets end the discussion with that. Even some docs write off the twitter results as anecdotal and paid shills. |
|
|
|
Post by lakon on Jan 31, 2017 14:20:20 GMT -5
You realize what you are suggesting is illegal and will have both the FDA and the SEC after Mannkind? The FDA will not allow a company to promote benefits that are not supported by trial data, and the SEC limit what you can say about the company. Although shareholder suits are probably a bigger risk if you go down this route - especially if the insurer can prove negligence and pass the cost back to Mannkind. Read more: mnkd.proboards.com/thread/7090/bring-noise#ixzz4WnPKleST
What is illegal about saying "no needles?" What is illegal about saying that Afrezza lowers A1C's? Why would shareholders file a lawsuit over transparency? Drugs are regulated and you cannot claim Afrezza lowers A1c unless there is a clinical trial. lets end the discussion with that. Even some docs write off the twitter results as anecdotal and paid shills. There were clinical trials. Afrezza lowers A1c. Afrezza is non-inferior to RAA. RAA is superior to RHI. Afrezza is RHI. IV infused RHI in a hospital setting gives the best results. Do you see what I did there? The Germans do. The FDA is full of horseshit, but opinions vary. I can make up a bunch of (re-)definitions and sound smart too as long as someone stands behind me with a gun. Get real. You mean that you MAY not claim, and you would be correct while still being so very wrong. At least the FDA is considering a protocol for anecdotal evidence, but we shall see how long that takes. Anecdotal evidence has value, just like uncoordinated data can be mined for value. For some "regulation" has become the dogma of the day. That said, yes, MNKD is going to stay within the regulatory and legal framework no matter what crazy ideas get posted on a message board, but let's not pretend that the current state of regulatory affairs is not part of the problem that needs fixed. Part of fixing it is objecting to it when wrong -- a founding principle of the USA. |
|
|
|
Post by wildthing on Jan 31, 2017 22:08:01 GMT -5
Drugs are regulated and you cannot claim Afrezza lowers A1c unless there is a clinical trial. lets end the discussion with that. Even some docs write off the twitter results as anecdotal and paid shills. There were clinical trials. Afrezza lowers A1c. Afrezza is non-inferior to RAA. RAA is superior to RHI. Afrezza is RHI. IV infused RHI in a hospital setting gives the best results. Do you see what I did there? The Germans do. The FDA is full of horseshit, but opinions vary. I can make up a bunch of (re-)definitions and sound smart too as long as someone stands behind me with a gun. Get real. You mean that you MAY not claim, and you would be correct while still being so very wrong. At least the FDA is considering a protocol for anecdotal evidence, but we shall see how long that takes. Anecdotal evidence has value, just like uncoordinated data can be mined for value. For some "regulation" has become the dogma of the day. That said, yes, MNKD is going to stay within the regulatory and legal framework no matter what crazy ideas get posted on a message board, but let's not pretend that the current state of regulatory affairs is not part of the problem that needs fixed. Part of fixing it is objecting to it when wrong -- a founding principle of the USA. Technically, no insulin lowers a1c since a1c represents the average blood sugar levels over time. Insulin, diet, exercise, patient compliance, etc, all contribute to lowering a1c. The question that needs to be answered in order to gain wider recognition and acceptance is whether use of afrezza makes a contribution that is significantly more than the use of RAAs. |
|
|
|
Post by sayhey24 on Feb 1, 2017 16:42:00 GMT -5
There were clinical trials. Afrezza lowers A1c. Afrezza is non-inferior to RAA. RAA is superior to RHI. Afrezza is RHI. IV infused RHI in a hospital setting gives the best results. Do you see what I did there? The Germans do. The FDA is full of horseshit, but opinions vary. I can make up a bunch of (re-)definitions and sound smart too as long as someone stands behind me with a gun. Get real. You mean that you MAY not claim, and you would be correct while still being so very wrong. At least the FDA is considering a protocol for anecdotal evidence, but we shall see how long that takes. Anecdotal evidence has value, just like uncoordinated data can be mined for value. For some "regulation" has become the dogma of the day. That said, yes, MNKD is going to stay within the regulatory and legal framework no matter what crazy ideas get posted on a message board, but let's not pretend that the current state of regulatory affairs is not part of the problem that needs fixed. Part of fixing it is objecting to it when wrong -- a founding principle of the USA. Technically, no insulin lowers a1c since a1c represents the average blood sugar levels over time. Insulin, diet, exercise, patient compliance, etc, all contribute to lowering a1c. The question that needs to be answered in order to gain wider recognition and acceptance is whether use of afrezza makes a contribution that is significantly more than the use of RAAs. Great response and the answer is, it depends on how afrezza is dosed. Since afrezza is the exact same monomer insulin as the pancreas releases into the blood, you would expect it to work the same and Surprise! it does. If you took a puff of afrezza to parallel when the pancreas had its phase 1 and phase 2 releases, Surprise! the results would be almost identical. If you under dose on the first puff and never take the second, Surprise! you will not beat a properly dosed RAA. But, give the PWD a CGM to make things easier to measure BG so they know when to dose, dollars to doughnuts they will beat an RAA every day of the week and reduce the chance of severe hypos. Why, one reason is unlike RAAs which kind-of mimics phase 2 release, afrezza to the liver looks like the pancreas and stops the liver from dumping sugar in the blood. Add in the natural speed of action and Boom, near natural results. |
|
